Haemonetics Corp. (HAE) Financials Nov 20, 2014, 4
Post# of 250666
Posted On: 11/20/2014 10:53:18 PM
Haemonetics Corp. (HAE) Financials Nov 20, 2014, 4:33 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Haemonetics Corp.
Fiscal year is April-March. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 645.43M 676.69M 727.84M 891.99M 938.51M
Cost of Goods Sold (COGS) incl. D&A 307.95M 321.49M 358.6M 463.86M 477.14M
COGS excluding D&A 264.71M 273.34M 308.64M 398.38M 395.4M
Depreciation & Amortization Expense 43.24M 48.15M 49.97M 65.48M 81.74M
Depreciation 35.5M 37M 38.6M 43.38M 52.54M
Amortization of Intangibles 7.74M 11.15M 11.37M 22.1M 29.2M
Gross Income 337.48M 355.21M 369.24M 428.13M 461.37M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 240.86M 247.32M 272.46M 323.5M 323.98M
Research & Development 26.38M 32.66M 36.8M 44.39M 50.6M
Other SG&A 214.48M 214.67M 235.66M 279.11M 273.38M
Other Operating Expense 0 0 0 0 0
Unusual Expense 12.81M (838,000) 8.02M 48.46M 90.06M
EBIT after Unusual Expense (12.81M) 838,000 (8.02M) (48.46M) (90.06M)
Non Operating Income/Expense (2.2M) 980,000 740,000 (371,000) (2.03M)
Non-Operating Interest Income 399,000 384,000 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 742,000 6,000 - 5.9M 8.9M
Gross Interest Expense 742,000 6,000 - 6.2M 9.3M
Interest Capitalized - 0 0 300,000 400,000
Pretax Income 81.27M 110.08M 89.5M 49.9M 36.4M
Income Tax 22.9M 30.1M 22.61M 11.1M 1.25M
Income Tax - Current Domestic 10.98M 17.09M 10.78M 5.12M (4.02M)
Income Tax - Current Foreign 9.33M 7.23M 5.95M 5.39M 5.48M
Income Tax - Deferred Domestic 4.36M 5.37M 6.93M 1.42M (1.58M)
Income Tax - Deferred Foreign (1.77M) 413,000 (1.05M) (826,000) 1.38M
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 - -
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income 58.37M 79.98M 66.89M 38.8M 35.15M
Minority Interest Expense 0 0 0 0 0
Net Income 58.37M 79.98M 66.89M 38.8M 35.15M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 58.37M 79.98M 66.89M 38.8M 35.15M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 58.37M 79.98M 66.89M 38.8M 35.15M
EPS (Basic) 1.15 1.60 1.32 0.76 0.68
Basic Shares Outstanding 50.9M 50.15M 50.73M 51.35M 51.61M
EPS (Diluted) 1.12 1.56 1.30 0.74 0.67
Diluted Shares Outstanding 52.13M 51.19M 51.59M 52.26M 52.38M
EBITDA 139.86M 156.03M 146.74M 170.11M 219.13M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Haemonetics Corp.
Fiscal year is April-March. All values USD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 645.43M 676.69M 727.84M 891.99M 938.51M
Cost of Goods Sold (COGS) incl. D&A 307.95M 321.49M 358.6M 463.86M 477.14M
COGS excluding D&A 264.71M 273.34M 308.64M 398.38M 395.4M
Depreciation & Amortization Expense 43.24M 48.15M 49.97M 65.48M 81.74M
Depreciation 35.5M 37M 38.6M 43.38M 52.54M
Amortization of Intangibles 7.74M 11.15M 11.37M 22.1M 29.2M
Gross Income 337.48M 355.21M 369.24M 428.13M 461.37M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 240.86M 247.32M 272.46M 323.5M 323.98M
Research & Development 26.38M 32.66M 36.8M 44.39M 50.6M
Other SG&A 214.48M 214.67M 235.66M 279.11M 273.38M
Other Operating Expense 0 0 0 0 0
Unusual Expense 12.81M (838,000) 8.02M 48.46M 90.06M
EBIT after Unusual Expense (12.81M) 838,000 (8.02M) (48.46M) (90.06M)
Non Operating Income/Expense (2.2M) 980,000 740,000 (371,000) (2.03M)
Non-Operating Interest Income 399,000 384,000 - 0 0
Equity in Affiliates (Pretax) 0 0 0 - -
Interest Expense 742,000 6,000 - 5.9M 8.9M
Gross Interest Expense 742,000 6,000 - 6.2M 9.3M
Interest Capitalized - 0 0 300,000 400,000
Pretax Income 81.27M 110.08M 89.5M 49.9M 36.4M
Income Tax 22.9M 30.1M 22.61M 11.1M 1.25M
Income Tax - Current Domestic 10.98M 17.09M 10.78M 5.12M (4.02M)
Income Tax - Current Foreign 9.33M 7.23M 5.95M 5.39M 5.48M
Income Tax - Deferred Domestic 4.36M 5.37M 6.93M 1.42M (1.58M)
Income Tax - Deferred Foreign (1.77M) 413,000 (1.05M) (826,000) 1.38M
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 - -
Other After Tax Income (Expense) - - - 0 0
Consolidated Net Income 58.37M 79.98M 66.89M 38.8M 35.15M
Minority Interest Expense 0 0 0 0 0
Net Income 58.37M 79.98M 66.89M 38.8M 35.15M
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries 58.37M 79.98M 66.89M 38.8M 35.15M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 58.37M 79.98M 66.89M 38.8M 35.15M
EPS (Basic) 1.15 1.60 1.32 0.76 0.68
Basic Shares Outstanding 50.9M 50.15M 50.73M 51.35M 51.61M
EPS (Diluted) 1.12 1.56 1.30 0.74 0.67
Diluted Shares Outstanding 52.13M 51.19M 51.59M 52.26M 52.38M
EBITDA 139.86M 156.03M 146.74M 170.11M 219.13M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)